Testosterone Replacement Therapy: Pros, Cons, and What to Ask Your Doctor

Testosterone replacement therapy (TRT) has moved from the fringes of men's health into mainstream medicine, and the conversation around it has become noisier than the evidence warrants. Some clinics market it as an anti-aging solution for every tired man over 40. Critics warn of heart attacks and prostate cancer. Neither framing reflects what the research actually shows.

This guide cuts through both. If you have confirmed low testosterone and want to understand what TRT can and cannot do, the real risks involved, and what to ask before signing up, this is where to start.

Medical disclaimer: This article is for educational purposes only and does not constitute medical advice. Testosterone replacement therapy is a prescription treatment. Discuss any hormone-related decisions with a board-certified physician or endocrinologist before proceeding.

What TRT Actually Is (and Who It's For)

Testosterone replacement therapy is a medical treatment that delivers exogenous testosterone to men whose bodies no longer produce adequate amounts. The clinical term for this condition is hypogonadism.

The American Urological Association defines clinical hypogonadism as a total testosterone level below 300 ng/dL, measured on two separate morning blood draws, combined with symptoms of deficiency. Both conditions must be present. Low numbers alone do not qualify a man for TRT under standard clinical guidelines, and symptoms alone without confirmed low labs are not grounds for a prescription either.

Before pursuing TRT, get the right tests. Most men test only total testosterone and miss the full picture. A complete workup includes total testosterone, free testosterone (the biologically active fraction), sex hormone-binding globulin (SHBG), LH, FSH, and a full metabolic panel. If you haven't done this yet, see our guide on how to get your testosterone levels checked.

If you're unsure whether your symptoms match a clinical pattern, review the 10 signs of low testosterone in men over 40 and discuss your findings with a physician who specializes in men's hormonal health.

You can also use our free testosterone calculator to compute your bioavailable testosterone from your lab values before your appointment — it gives your doctor a more complete picture than total T alone.

The Benefits of TRT: What the Evidence Supports

TRT works. When prescribed to men with confirmed hypogonadism, it produces measurable, clinically significant improvements across multiple systems.

Restored Libido and Sexual Function

The European Male Aging Study, published in the New England Journal of Medicine in 2010 and based on data from 3,369 men aged 40-79, identified reduced libido and erectile dysfunction as the two symptoms most specifically associated with low testosterone. TRT consistently restores libido in hypogonadal men.

A meta-analysis published in JAMA (2016) covering 58 randomized controlled trials found that TRT produced statistically significant improvements in sexual desire and erectile function compared to placebo in men with confirmed hypogonadism.

Muscle Mass and Strength Recovery

Testosterone is anabolic. It drives muscle protein synthesis, and when levels fall, lean body mass falls with it regardless of training status.

Bhasin et al., in a landmark study published in the New England Journal of Medicine (2001), demonstrated that testosterone administration produced dose-dependent increases in muscle volume and strength, with the largest gains in men at the lowest baseline levels. Replacing a deficit restores capacity. For men over 40 already dealing with age-related muscle loss, restoring testosterone to mid-normal range can make resistance training productive again.

Energy and Mood

Fatigue and low drive are among the most consistent complaints from men with low T, and among the most consistent improvements reported after TRT. A 2015 study in the Journal of Clinical Endocrinology and Metabolism found that men with hypogonadism who received TRT reported significant reductions in fatigue and depressive symptoms compared to those receiving placebo over 52 weeks.

Testosterone receptors are present throughout the central nervous system. The hormone directly influences dopaminergic and serotonergic pathways, which explains why the mood effects are often the first thing men notice after starting treatment.

Bone Density

Men lose bone density after 40, with the rate accelerating after 50. Low testosterone compounds this loss. TRT increases bone mineral density in hypogonadal men, a finding consistent across multiple trials. The clinical significance is reduced fracture risk, particularly relevant for men with osteopenia identified during routine screening.

Cognitive Function

Evidence here is less robust than in the domains above, but it points in a consistent direction. The Testosterone Trials (TTrials), a consortium of seven coordinated studies published between 2016 and 2018, found modest improvements in memory and spatial ability in older hypogonadal men receiving TRT versus placebo. Effects were small but present, particularly in men with baseline cognitive symptoms.

The Risks of TRT: What You Need to Know

No meaningful medical intervention comes without risk. TRT is no exception. Knowing what the evidence actually says, as opposed to worst-case headlines, lets you make an informed decision.

Cardiovascular Risk: The TRAVERSE Trial Settled Most of the Debate

For years, TRT carried a contested cardiovascular warning. Two observational studies published around 2014 suggested increased risk of heart attack and stroke in older men receiving TRT, triggering an FDA label update in 2015 requiring a cardiovascular risk statement on all testosterone products.

The TRAVERSE trial, published in the New England Journal of Medicine in 2023, resolved most of that uncertainty. The trial enrolled 5,198 men aged 45-80 with hypogonadism and pre-existing or high risk of cardiovascular disease, randomized to testosterone gel or placebo for up to 33 months. The primary finding: TRT did not increase the risk of major adverse cardiovascular events (MACE), including heart attack, stroke, or cardiovascular death.

However, TRAVERSE also found that TRT significantly increased the risk of atrial fibrillation and acute kidney injury compared to placebo. The absolute rates were low, but the signals were real. If you have existing atrial fibrillation or compromised kidney function, that changes your risk calculation in a conversation with your physician.

Polycythemia (Blood Thickening)

TRT stimulates red blood cell production. In some men, hematocrit climbs above 54%, thickening the blood and raising the risk of clots, stroke, and pulmonary embolism. This is the most common serious adverse effect seen in clinical practice.

Monitoring is the answer, not avoidance. Men on TRT get hematocrit checks every 3-6 months. Dose adjustments, therapeutic phlebotomy, or a switch in delivery method (injections tend to spike hematocrit more than gels due to level peaks) can manage the issue in most cases.

Infertility

This is the most underexplained risk in TRT discussions, and the one that catches men off guard.

Exogenous testosterone suppresses the hypothalamic-pituitary-gonadal axis. The pituitary stops sending LH and FSH signals to the testes, which halts both natural testosterone production and sperm production. Studies show azoospermia (zero sperm in semen) in 40-90% of men on TRT within six months of starting treatment.

In most men, sperm production recovers after stopping TRT, but recovery is not guaranteed, and it can take 12-24 months. If you are under 50, have not yet had children, or have any interest in future fertility, discuss this explicitly before starting. Options include concurrent HCG therapy to preserve testicular function, or choosing alternative treatments entirely.

Testicular Atrophy

The same axis suppression that stops sperm production also reduces testicular volume. In most men, the change is cosmetic rather than functionally significant, but it is consistent and expected. HCG co-therapy prevents this by maintaining LH-receptor stimulation in the testes.

Prostate Health

TRT does not cause prostate cancer. This was the dominant concern for decades, based on Huggins' 1941 observation that testosterone fueled existing prostate cancer growth. More recent evidence, including long-term data from the Testosterone Trials, does not support a causal link between TRT and prostate cancer development in men with confirmed hypogonadism.

That said, TRT remains contraindicated in men with known or suspected prostate cancer. PSA monitoring is standard protocol: baseline PSA before starting, then testing at 3 months, 6 months, and annually thereafter. A rise of more than 1.4 ng/mL over any 12-month period warrants urological evaluation.

Sleep Apnea

Testosterone can worsen obstructive sleep apnea by altering upper airway muscle tone during sleep. If you already have untreated sleep apnea, TRT can make it meaningfully worse. Untreated sleep apnea itself lowers testosterone, creating a cycle that requires addressing both problems.

Get a sleep study before starting TRT if you snore heavily, stop breathing during sleep, or wake unrefreshed. Treating sleep apnea first sometimes brings testosterone levels back into normal range without TRT.

Delivery Methods Compared

TRT comes in several forms. Each has tradeoffs.

Injections remain the most studied and cost-effective option. Subcutaneous weekly injections now outperform the traditional biweekly intramuscular method for level stability and hematocrit management. Gels are appropriate for men who cannot or will not self-inject, but skin transfer to female partners and children is a real safety concern requiring consistent application hygiene.

What to Ask Your Doctor Before Starting TRT

Most men receive inadequate explanations before starting testosterone therapy. These questions ensure you understand what you are agreeing to.

1. Do I meet the clinical criteria? Ask for your exact lab values, not just a judgment of "low." Confirm total testosterone, free testosterone, and SHBG. Confirm the tests were taken before 10 AM on two separate mornings.

2. What is causing my low testosterone? Primary hypogonadism (testes not producing T) and secondary hypogonadism (pituitary not signaling correctly) have different underlying causes and sometimes different treatments. Secondary causes, including obesity, hypothyroidism, and hyperprolactinemia, can sometimes be corrected directly without lifelong TRT.

3. What is your monitoring protocol? A responsible prescriber schedules labs at 3 months (hematocrit, PSA, T levels), 6 months, and annually. Any clinic that cannot describe their monitoring schedule is not managing this safely.

4. How will this affect my fertility? If you have any interest in fathering children now or in the future, raise this before your first injection. Ask about HCG co-therapy or discuss sperm banking.

5. What are my alternatives? Lifestyle optimization can raise testosterone 100-200 ng/dL in some men. Resistance training, consistent sleep, body fat reduction, and targeted nutrition all move the needle. See best foods to boost testosterone naturally and the evidence on whether testosterone boosters actually work as a starting point for a non-prescription approach.

6. Is this a lifetime commitment? For men with primary hypogonadism, typically yes. For secondary hypogonadism driven by lifestyle or correctable causes, it depends on whether the underlying problem can be resolved. Stopping TRT causes testosterone to drop, often below pre-treatment baseline for several months while the HPGA reactivates.

7. What will success look like, and how will we measure it? Define specific symptom targets at the start. A physician who cannot tell you what "working" looks like in quantifiable terms is prescribing on faith rather than medicine.

Who Should Not Start TRT

TRT is contraindicated in men with:

• Known or suspected prostate cancer or breast cancer
• Untreated obstructive sleep apnea
• Hematocrit above 54%
• Recent cardiovascular event (heart attack or stroke within 6 months)
• Severe lower urinary tract symptoms from BPH (benign prostatic hyperplasia)
• Active desire for biological children without a fertility preservation plan

Is TRT Worth It?

For a man with confirmed hypogonadism, bothersome symptoms, and no contraindications, TRT is a legitimate and effective treatment. The benefits are not hypothetical. The risks are manageable with proper monitoring. The error is using it as a lifestyle supplement rather than a medical treatment.

For men in the 300-400 ng/dL range with vague fatigue and motivation problems, the picture is less clear. Research consistently shows the benefits of TRT are most pronounced in men with clinically low testosterone, not those at the low end of normal. Optimizing sleep, body composition, resistance training, and diet first is not just caution — it is good medicine. If you address those variables and still test below 300 ng/dL with persistent symptoms, that is a reasonable point to have a deeper conversation with a specialist.

Frequently Asked Questions

How long does TRT take to work?

Libido improvements typically appear within 3-6 weeks. Energy and mood changes are often noticeable within 3-4 weeks. Muscle composition changes require 3-6 months of consistent therapy combined with resistance training. Bone density changes take 12-24 months to register on DEXA scans.

Can I stop TRT once I start?

Yes, but expect a period of suppressed testosterone before natural production recovers. For most men on TRT for fewer than two years, natural production resumes within 3-12 months of stopping, sometimes supported by a structured post-therapy protocol using clomiphene or HCG. Men on TRT for longer periods may take longer to recover.

Does TRT increase the risk of prostate cancer?

Current evidence does not support a causal link between TRT and prostate cancer in men with hypogonadism. The Testosterone Trials and subsequent long-term follow-up have not found increased prostate cancer incidence. TRT remains contraindicated in men with existing or suspected prostate cancer.

Will TRT make me aggressive or emotionally unstable?

At therapeutic doses targeting mid-normal physiological range (typically 400-700 ng/dL), no. The aggression stereotype comes from supraphysiological dosing, the kind seen in anabolic steroid abuse, not medical TRT. Men on therapeutic doses typically report improved mood stability, not increased irritability.

Can TRT be done entirely at home?

With telehealth TRT services, injections and topical applications can be self-administered at home. Laboratory monitoring still requires in-person blood draws. Any program offering TRT without requiring regular hematocrit, PSA, and testosterone labs is not practicing responsible medicine.

What is the difference between TRT and anabolic steroids?

TRT uses testosterone to restore physiological levels, typically targeting 400-700 ng/dL total testosterone. Anabolic steroid use involves supraphysiological doses, sometimes 5-20 times normal levels, often combined with other synthetic androgens. The molecules may overlap, but the doses, monitoring, and risk profiles are entirely different.

Key Takeaways

• TRT is a medical treatment for confirmed hypogonadism (T below 300 ng/dL plus symptoms), not a general anti-aging supplement
• The TRAVERSE trial (NEJM, 2023) found TRT did not increase major cardiovascular events, but did raise atrial fibrillation risk in high-risk men
• Infertility affects 40-90% of men on TRT: always discuss HCG co-therapy if fathering children matters to you
• Monitoring hematocrit and PSA every 3-6 months is non-negotiable, not optional
• Lifestyle optimization comes first for borderline testosterone levels; TRT shows the strongest benefit in men with clearly confirmed deficiency

Consult a board-certified endocrinologist or urologist before starting testosterone replacement therapy. Never adjust hormone treatment without physician supervision.